332 related articles for article (PubMed ID: 7841039)
1. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
[TBL] [Abstract][Full Text] [Related]
2. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
3. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
[TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
Swaim MW; Chiang HS; Huang TF
Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
[TBL] [Abstract][Full Text] [Related]
6. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
[TBL] [Abstract][Full Text] [Related]
7. Characterization of integrin expression and regulation on SW-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion.
Chiang HS; Peng HC; Huang TF
Biochim Biophys Acta; 1994 Dec; 1224(3):506-16. PubMed ID: 7803510
[TBL] [Abstract][Full Text] [Related]
8. Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1996 Apr; 73(7):902-8. PubMed ID: 8611404
[TBL] [Abstract][Full Text] [Related]
9. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.
Sheu JR; Lin CH; Peng HC; Huang TF
Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826
[TBL] [Abstract][Full Text] [Related]
10. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
[TBL] [Abstract][Full Text] [Related]
11. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide.
Ugen KE; Mahalingam M; Klein PA; Kao KJ
J Natl Cancer Inst; 1988 Nov; 80(18):1461-6. PubMed ID: 3184195
[TBL] [Abstract][Full Text] [Related]
13. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
14. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
15. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
Knapp A; Degenhardt T; Dodt J
J Biol Chem; 1992 Dec; 267(34):24230-4. PubMed ID: 1447173
[TBL] [Abstract][Full Text] [Related]
16. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
Rahman S; Lu X; Kakkar VV; Authi KS
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
18. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.
Sheu JR; Lin CH; Peng HC; Huang TF
Peptides; 1994; 15(8):1391-8. PubMed ID: 7700842
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
[TBL] [Abstract][Full Text] [Related]
20. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
Mohri H; Ohkubo T
Am J Clin Pathol; 1991 Nov; 96(5):605-9. PubMed ID: 1719797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]